Based on information to date, Hagens Berman attorneys believe that Abiomed may have run into trouble by continuing to make comparative representations using the terminated Protect II trials. Abiomed reportedly pulled all of its marketing materials off its website and from its field representatives in August. Copies of these pulled materials would be helpful in advancing the firm’s investigation . Destruction of evidence, including emails and marketing/presentation materials by a company or its employees to impede known investigations, has severe consequences under both criminal and civil laws.Whistleblowers
Hagens Berman Continues Abiomed Investigation Into Possible Securities Law Violations On Behalf Of Investors
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.